INS and obesity disorder: Insulin receptor resistance, also associated with inflammatory cytokines in obesity (269), is expected to potentiate both these lipolytic dysregulations, exacerbating both adipose and hepatic lipid accumulation while diminishing the validity of serum FFA level as a marker of the fasting state.